Cargando…
Profile of Bacterial Infections in COVID-19 Patients: Antimicrobial Resistance in the Time of SARS-CoV-2
SIMPLE SUMMARY: Since the beginning of COVID-19 pandemic, no specific drugs have been available to treat the SARS-CoV-2 infection, therefore antibiotics have been often used both for prophylactic and therapeutic purposes. Their wide use, though, is known to contribute to the emergence of antimicrobi...
Autores principales: | Stefanini, Irene, De Renzi, Giuseppe, Foddai, Elisa, Cordani, Elisa, Mognetti, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467430/ https://www.ncbi.nlm.nih.gov/pubmed/34571699 http://dx.doi.org/10.3390/biology10090822 |
Ejemplares similares
-
Antimicrobial Resistance, an Update from the Ward: Increased Incidence of New Potential Pathogens and Site of Infection-Specific Antibacterial Resistances
por: Stefanini, Irene, et al.
Publicado: (2020) -
Principles of SARS-CoV-2 glycosylation
por: Chawla, Himanshi, et al.
Publicado: (2022) -
Origin and evolution of SARS-CoV-2
por: Pagani, Isabel, et al.
Publicado: (2023) -
Profile of SARS-CoV-2
por: Heinz, Franz X., et al.
Publicado: (2020) -
Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection
por: Townsend, Liam, et al.
Publicado: (2020)